Dr. Cécile Tremblay is a professor in the Department of Microbiology and Immunology at the Université de Montréal as well as a microbiologist infectious disease specialist and director of research at the Centre hospitalier de l’Université de Montréal. She is also a researcher and co-director of the AIDS Network of the Fonds de recherché du Québec – Santé, Quebec’s health research funding body.
She first obtained her nursing diploma from CÉGEP St-Laurent, then earned her medical degree at the Université de Montréal and completed post-doctoral training in infectious diseases, microbiology, and internal medicine.
Dr. Tremblay studies the viral evolution of HIV in different immunotherapeutic contexts, the genetic evolution of different HIV sub-types, the determinants of the HIV disease progression, and HIV resistance mechanisms and entry inhibitors.
Dr. Tremblay is involved in numerous CTN studies. She is studying the determinants of HIV progression in CTN 247, which is investigating the factors associated with slower than normal progression in a certain segment of the HIV-positive population. Dr. Tremblay is leading two CTN studies, CTN 272: Canadian HIV and Aging cohort and CTN 288: LHIVE Healthy and as co-investigator for CTN 268 and CTN 257. She has contributed to over 30 CTN research publications on her own studies as well as those of other CTN investigators.